1. 1567Simplification to elvitegravir/cobicistat/emtricitabine/tenofovir DF from ritonavir-boosted protease inhibitor plus emtricitabine/tenofovir DF maintains HIV suppression and improves fasting triglycerides at week 48. (December 2014) Authors: Cunningham, Douglas; Shamblaw, David; Zurawski, Christine; Robbins, William; Scarsella, Anthony; Nguyen, Thai; Hindman, Jason; Ebrahimi, Ramin; Piontkowsky, David Journal: Open forum infectious diseases Issue: Volume 1(2014)Supplement 1 Page Start: S417 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and Safety of Tenofovir Alafenamide vs. Tenofovir Disoproxil Fumarate in HIV-infected, Virologically Suppressed Black and Non-Blacks Adults Through Week 96: Subgroup Analysis of a Randomized Switch Study. (4th October 2017) Authors: Flamm, Jason A; Vanig, Thanes; Gathe, Joseph; Kinder, Clifford; Para, Michael; Rashbaum, Bruce; Segal-Maurer, Sorana; Shamblaw, David; Wohlfeiler, Michael; Young, Benjamin; Zurawski, Christine; Rhee, Martin S Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S427 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study. Issue 1 (January 2016) Authors: Mills, Anthony; Arribas, Jose R; Andrade-Villanueva, Jaime; DiPerri, Giovanni; Van Lunzen, Jan; Koenig, Ellen; Elion, Richard; Cavassini, Matthias; Madruga, Jose Valdez; Brunetta, Jason; Shamblaw, David; DeJesus, Edwin; Orkin, Chloe; Wohl, David A; Brar, Indira; Stephens, Jeffrey L; Girard, Pierr... Journal: Lancet infectious diseases Issue: Volume 16:Issue 1(2016:Jan.) Page Start: 43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate in the First Protease Inhibitor–Based Single-Tablet Regimen for Initial HIV-1 Therapy: A Randomized Phase 2 Study. (1st August 2015) Authors: Mills, Anthony; Crofoot, Gordon; McDonald, Cheryl; Shalit, Peter; Flamm, Jason A.; Gathe, Joseph; Scribner, Anita; Shamblaw, David; Saag, Michael; Cao, Huyen; Martin, Hal; Das, Moupali; Thomas, Anne; Liu, Hui C.; Yan, Mingjin; Callebaut, Christian; Custodio, Joseph; Cheng, Andrew; McCallister, Scott Journal: Journal of acquired immune deficiency syndromes Issue: Volume 69:Number 4(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗